PolyGlycopleX (PGX)
Dietary SupplementThe full dose of the study intervention is 15 grams per day and total number of calories with the LCD is 1000 kcal/day.
NCT Number: NCT01109199
This 18 week, randomized, double blind, placebo controlled trial will examine the effects of thick dietary fibre (PGX) supplementation of a low calorie diet (LCD) on appetite, weight loss, body composition, and compliance in overweight and moderately obese female.
The investigators believe that 15 grams/day PGX supplementation of a low calorie diet over a 14-weeks period will elicit a better appetite score (e.g. reduced hunger) compared to the rice flour supplementation of the LCD.
Looking for future studies?
Notify Me20 year–55 year
Female
Interventional
Phase 3
Canadian Center for Functional Medicine, Coquitlam, British Columbia, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The full dose of the study intervention is 15 grams per day and total number of calories with the LCD is 1000 kcal/day.
The full dose of the placebo comparator is 15 grams per day and total number of calories with the LCD is 1000 kcal/day.
Time frame: 18 weeks
Time frame: 18 weeks
Time frame: 18 weeks
Canadian Center for Functional Medicine
Other
A Randomized, Double Blind, Placebo Controlled Trial Evaluating the Effects of a High Viscosity Dietary Fibre (PGX) Supplementation of a Low Calorie Diet on Appetite and Body Weight, in Overweight and Moderately Obese Females
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02774486
Appetite Regulation, Appetite Suppression
Berlin, Germany
View Trial DetailsNCT00687115
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT05184361
Body Weight, Body Weight Changes
Cruz Quebrada, Lisbon District, Portugal
View Trial DetailsNCT07718516
Body Weight, Body Weight Changes
New York, United States
View Trial Details